{"id":"W2507796609","doi":"10.1016/j.jid.2016.06.077","title":"060 Integrated safety of ixekizumab in patients with moderate-to-severe psoriasis: results from a pooled analysis of 7 clinical trials","year":2016,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Placebo; Adverse effect; Psoriasis; Internal medicine; Secukinumab; Dermatology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0118042,0.001655717,0.007315118,0.001160266,0.000317828,0.002587845,0.0007391541,0.001552469,0.002304109],"category_scores_gemma":[0.008987493,0.0009396434,0.01711427,0.001573089,0.0006958595,0.001301916,0.0008718889,0.001610866,0.0003797415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007057888,"about_ca_system_score_gemma":0.0008032412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005952902,"about_ca_topic_score_gemma":0.00136596,"domain_scores_codex":[0.9908664,0.005467039,0.00118822,0.001266554,0.0008355237,0.0003762703],"domain_scores_gemma":[0.9944713,0.002761178,0.00152932,0.0005484436,0.0004794722,0.0002103895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.3641976,0.0003941779,0.02246993,0.01144685,0.5416188,0.0001316973,0.00008372945,0.001539967,0.003314686,0.0001559238,0.001178022,0.0534686],"study_design_scores_gemma":[0.1653102,0.02605635,0.07294951,0.001216934,0.7266069,0.0003842342,0.0001314414,0.001200167,0.001571998,0.0006177831,0.003829171,0.0001253214],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6011992,0.3848285,0.003814412,0.0007692846,0.0007057306,0.001035699,0.003629844,0.000162084,0.003855173],"genre_scores_gemma":[0.9702612,0.02423646,0.001372653,0.0006686688,0.0004983269,0.0003376959,0.001974635,0.00004089619,0.0006093803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0118042,"threshold_uncertainty_score":0.06242728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05319128426273027,"score_gpt":0.3155931721780265,"score_spread":0.2624018879152962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}